Caption Management, LLC Igm Biosciences, Inc. Put Options Transaction History
Caption Management, LLC
- $10.8 Billion
- Q3 2025
Put Options
5 transactions
Others Institutions Holding IGMS
# of Institutions
24Shares Held
9.61MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY883KShares$1.12 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny275KShares$349,3920.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT164KShares$208,5450.0% of portfolio
-
Northern Trust Corp Chicago, IL108KShares$136,6110.0% of portfolio
-
Woodline Partners LP San Francisco, CA69.6KShares$88,3610.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $36.8M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...